For patients with symptomatic aortic regurgitation at high surgical risk, a transcatheter aortic valve replacement system exceeded safety and performance goals, according to results of the ALIGN-AR ...

Patients with severe aortic stenosis had comparable rates of death or disabling stroke, but the lead investigator cautions ...

With surveillance, conversion to acute valve syndrome happened frequently and was linked to worse clinical outcomes.

Medtronic has reported late-breaking data from the Evolut Low Risk Trial’s five-year outcomes of the Evolut TAVR system.

Medtronic, Abbott and Boston Scientific had updates on their devices used in heart valve disease treatment at the event.

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter aortic valve replacement (TAVR) had similar rates of death or disabling ...

and study's first author TAVR is a common procedure carried out to treat patients with aortic stenosis, a condition in which the aortic valve becomes narrowed, preventing blood from flowing properly.

TAVR is a minimally invasive treatment option for Aortic Valve Stenosis and is an alternative to open-aortic valve replacement surgery. TAVR is a procedure in which a small cut is made in the ...

Data shows, versus surgery, the Evolut™ transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of all-cause mortality or disabling stroke at five years ...

Transcatheter Aortic Valve Replacement Market outlook through 2035, highlighting key trends, growth drivers, challenges, and future opportunities ...

The solution? TAVR, or Transcatheter Aortic Valve Replacement, a procedure Providence Alaska Medical Center introduced to ...